Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.70) per share. This is a 45.83 percent decrease over losses of $(0.48) per share from the same period last year.
Dover Divests DESTACO Business Unit For $680M To Focus On Its Core Platforms
Industrial products maker Dover Corp (NYSE: DOV) has entered into a definitive agreement to sell its De-Sta-Co business (DESTACO), which is part of its Engineered Products segment, to Stabilus SE (OTC: SIUAF<
